{"nct_id":"NCT02864394","title":"Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2016-09-07","start_date_type":"ACTUAL","primary_completion_date":"2019-09-09","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}